Press Release Oxford Square Capital Corp. Schedules Second Quarter 2026 Earnings Release and Conference Call for July 31, 2026 Oxford Square Capital Corp. · Jul 27
Press Release NOBLE CORPORATION PLC ANNOUNCES SECOND QUARTER 2026 RESULTS Noble Corporation plc · Jul 27
Press Release 21shares Introduces 1-Year Fee Waiver on 21shares Solana ETF (ticker: TSOL) 21Shares · Jul 27
Press Release Gibson Energy Reports Second Quarter 2026 Results, Highlighted by Record Infrastructure Adjusted EBITDA and Strategic Growth Execution Gibson Energy Inc. · Jul 27
Press Release Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer Kymera Therapeutics, Inc. · Jul 27
Press Release Cerence to Announce Fiscal Third Quarter Results on August 6, 2026 Cerence Operating Company · Jul 27
Press Release Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement Scribe Therapeutics Inc. · Jul 27
Press Release Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026 Denali Therapeutics Inc. · Jul 27
Press Release Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) Definitive Healthcare Corp. · Jul 27
Press Release Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 Nyxoah · Jul 27
Press Release Robin Energy Announces Closing of $3.0 Million Public Offering of Common Stock Robin Energy Ltd. · Jul 27
Press Release Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers Organogenesis Holdings Inc. · Jul 27